Astellas Pharma Inc (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2018 | 09-2018 | 06-2018 | 12-2017 | 09-2017 | |
| Sales | 0 | 0 | 3,027,582 | 0 | 0 |
| Cost of Goods | N/A | N/A | 650,771 | N/A | 0 |
| Gross Profit | N/A | N/A | 2,376,811 | N/A | 0 |
| Operating Expenses | 0 | 0 | 1,792,931 | 0 | 0 |
| Operating Income | N/A | N/A | 584,642 | N/A | 0 |
| Interest Expense | 0 | 0 | 2,015 | 0 | 0 |
| Other Income | 0 | 0 | 10,727 | 0 | 0 |
| Pre-tax Income | 0 | 0 | 593,354 | 0 | 0 |
| Income Tax | N/A | N/A | 91,402 | N/A | 0 |
| Net Income Continuous | N/A | N/A | 501,952 | N/A | 0 |
| Net Income | $N/A | $N/A | $501,943 | $N/A | $0 |
| EPS Basic Total Ops | N/A | N/A | 0.25 | N/A | N/A |
| EPS Basic Continuous Ops | N/A | N/A | 0.25 | N/A | N/A |
| EPS Diluted Total Ops | N/A | N/A | 0.25 | N/A | N/A |
| EPS Diluted Continuous Ops | N/A | N/A | 0.25 | N/A | N/A |
| EBITDA(a) | $N/A | $N/A | $732,587 | $N/A | $0 |